Wayne Williams Acquires 10,810 Shares of Callan JMB (NASDAQ:CJMB) Stock

Callan JMB Inc. (NASDAQ:CJMBGet Free Report) CEO Wayne Williams bought 10,810 shares of the stock in a transaction dated Monday, December 15th. The shares were purchased at an average cost of $1.70 per share, for a total transaction of $18,377.00. Following the completion of the purchase, the chief executive officer owned 79,355 shares in the company, valued at approximately $134,903.50. This represents a 15.77% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Callan JMB Stock Up 3.5%

Shares of Callan JMB stock opened at $1.77 on Wednesday. The firm has a market cap of $8.18 million and a PE ratio of -1.43. Callan JMB Inc. has a twelve month low of $1.20 and a twelve month high of $7.76. The business has a 50-day moving average price of $3.28 and a 200 day moving average price of $4.32.

Callan JMB (NASDAQ:CJMBGet Free Report) last issued its quarterly earnings data on Friday, November 14th. The company reported ($0.61) EPS for the quarter. The business had revenue of $1.45 million during the quarter. Callan JMB had a negative net margin of 112.72% and a negative return on equity of 133.43%.

Hedge Funds Weigh In On Callan JMB

A hedge fund recently bought a new stake in Callan JMB stock. HighTower Advisors LLC purchased a new position in shares of Callan JMB Inc. (NASDAQ:CJMBFree Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 12,500 shares of the company’s stock, valued at approximately $56,000. HighTower Advisors LLC owned approximately 0.28% of Callan JMB as of its most recent filing with the Securities & Exchange Commission.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Callan JMB in a research report on Monday, December 8th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Callan JMB presently has a consensus rating of “Sell”.

Check Out Our Latest Stock Analysis on CJMB

About Callan JMB

(Get Free Report)

Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility.

Featured Articles

Insider Buying and Selling by Quarter for Callan JMB (NASDAQ:CJMB)

Receive News & Ratings for Callan JMB Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Callan JMB and related companies with MarketBeat.com's FREE daily email newsletter.